Sign up Australia
Proactive Investors - Run By Investors For Investors

Roto-Gro International Ltd begins delivery of hydroponic system order

The company is focusing on the rapidly expanding medical cannabis market.
Roto-Gro International Ltd begins delivery of hydroponic system order
Roto-Gro is continuing to increase the production of hydroponic systems

Roto-Gro International Ltd (ASX:RGI) has completed the initial delivery of its order from EuroAg Corporation for the supply of 240 Roto-Gro Units over a 12 month period.

The fully-automated Roto-Gro rotary hydroponic system (a method of growing plants without soil) can be used to produce high-quality medical cannabis at a competitive cost.

The delivery of the Roto-Gro units to EuroAg is the result of an up-scaled manufacturing schedule.

In addition, the company is currently delivering several Roto-Gro units to other customers’ testing facilities in the emerging medical cannabis and vertical farming markets.

Following the fulfilment of all current orders, the company will continue to increase the production of Roto-Gro units to enable a substantial number of completed units to be held in inventory.

Roto-Gro is also discussing with universities and research institutions throughout North America and Australia to conduct efficacy studies and trials for the purpose of generating data for customers.

The Roto-Gro System was designed and manufactured in Canada in late 2006 and has undergone continuous improvement since that date.

Between 2007 and 2012, about 600 units have been sold worldwide by Canadian distributor NutriLife Products.

Roto-Gro is capitalising on the immediate opportunity in the rapidly expanding lawful medical cannabis market, with a focus on North America, Europe and Australia.

The new market in Australia is a significant opportunity for peripheral industries, specifically those that help grow, extract and distribute cannabis products.





Register here to be notified of future RGI Company articles
View full RGI profile View Profile

Roto-Gro International Ltd Timeline

Related Articles

Novogen: Access latest PPT from Proactive's CEO Sessions
April 13 2017
Dr James Garner talked clinical-stage programs with investors.
e-Therapeutics
August 17 2017
E-Therapeutics’ network-driven drug discovery platform looks at the broader interactions within disease mechanisms
newspaper with word cancer magnified
July 11 2017
"In our view, the potential for SCIB1 [Scancell's skin cancer treatment], as already demonstrated by the survival data, is remarkable," said one broker recently

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use